A V1143F mutation in the neuronal-enriched isoform 2 of the PMCA pump is linked with ataxia

The fine regulation of intracellular calcium is fundamental for all eukaryotic cells. In neurons, Ca²⁺ oscillations govern the synaptic development, the release of neurotransmitters and the expression of several genes. Alterations of Ca²⁺ homeostasis were found to play a pivotal role in neurodegenerative progression. The maintenance of proper Ca²⁺ signaling in neurons demands the continuous activity of Ca²⁺ pumps and exchangers to guarantee physiological cytosolic concentration of the cation. The plasma membrane Ca²⁺ATPases (PMCA pumps) play a key role in the regulation of Ca²⁺ handling in selected sub-plasma membrane microdomains. Among the four basic PMCA pump isoforms existing in mammals, isoforms 2 and 3 are particularly enriched in the nervous system. In humans, genetic mutations in the PMCA2 gene in association with cadherin 23 mutations have been linked to hearing loss phenotypes, while those occurring in the PMCA3 gene were associated with X-linked congenital cerebellar ataxias. Here we describe a novel missense mutation (V1143F) in the calmodulin binding domain (CaM-BD) of the PMCA2 protein. The mutant pump was present in a patient showing congenital cerebellar ataxia but no overt signs of deafness, in line with the absence of mutations in the cadherin 23 gene. Biochemical and molecular dynamics studies on the mutated PMCA2 have revealed that the V1143F substitution alters the binding of calmodulin to the CaM-BD leading to impaired Ca²⁺ ejection.